Manufacturers should show that any new technology or process not only satisfies the prevailing expectations for sterility assurance and also delivers tangible Added benefits in terms of performance, trustworthiness, or product or service basic safety. As these new technologies emerge, the WHO emphasizes the value of an intensive chance waiting for link from Forum Profiles (11)